Literature DB >> 6264297

Immunoregulatory T cells in mononucleosis and toxoplasmosis.

M De Waele, C Thielemans, B Van Camp.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6264297     DOI: 10.1056/NEJM198107233050422

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Acute pulmonary toxoplasmosis with alveolitis of T suppressor lymphocyte type.

Authors:  O Michel; R Sergysels
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

2.  Activated T-cells with suppressor/cytotoxic phenotype in acute Toxoplasma gondii infection.

Authors:  M De Waele; A Naessens; W Foulon; B van Camp
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

Authors:  U Köller; O Majdic; K Liszka; H Stockinger; I Pabinger-Fasching; K Lechner; W Knapp
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  The exanthem of Ross River virus infection: histology, location of virus antigen and nature of inflammatory infiltrate.

Authors:  J R Fraser; V M Ratnamohan; J P Dowling; G J Becker; G A Varigos
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

5.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.

Authors:  H W Roenhorst; J M Beelen; J M Middeldorp; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia.

Authors:  U Köller; W Hinterberger; L Gschwandtler; R Grümayer; O Majdic; W Knapp
Journal:  Blut       Date:  1989-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.